Data from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma

Autor: Daniel V. Catenacci, Adam J. Bass, Jeeyun Lee, Viktor Adalsteinsson, Yu Imamura, Jon Davison, Denisse Rotem, Greg Gydush, Sarah Reed, Justin Rhoades, Samuel S. Freeman, Gavin Ha, Andres Gelrud, Uzma Siddiqui, Kyle Hogarth, Paul Chang, Kiran Turaga, Kevin Roggin, Mitchell C. Posner, Yuan Ji, Haley A. Coleman, Bruce M. Wollison, Matthew D. Ducar, Aaron R. Thorner, Andrew Dunford, David J. Oh, Agoston T. Agoston, Rick Lanman, Hideo Baba, Masayuki Watanabe, Lea O'Keefe, Katie S. Nason, Byung-Hoon Min, Min-Gew Choi, Kyoung-Mee Kim, Rebecca J. Nagy, John Hart, Shu-Yuan Xiao, Namrata Setia, Christopher Weber, Carrie Fitzpatrick, Rajani Kanteti, Melissa Maranto, Samantha Lomnicki, Emily O'Day, Kenisha Allen, Manish R. Sharma, Blase Polite, Hedy Kindler, Heewon Kwak, Lindsay Alpert, Mirazul Islam, Steven Maron, Yang Liu, Sarah Derks, Matthew D. Stachler, Eirini Pectasides

Gastroesophageal adenocarcinoma (GEA) is a lethal disease where targeted therapies, even when guided by genomic biomarkers, have had limited efficacy. A potential reason for the failure of such therapies is that genomic profiling results could common

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b6ea79102b00169cfaf145b8d3b0505
https://doi.org/10.1158/2159-8290.c.6547418.v1

Supplementary Methods from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma

Autor: Daniel V. Catenacci, Adam J. Bass, Jeeyun Lee, Viktor Adalsteinsson, Yu Imamura, Jon Davison, Denisse Rotem, Greg Gydush, Sarah Reed, Justin Rhoades, Samuel S. Freeman, Gavin Ha, Andres Gelrud, Uzma Siddiqui, Kyle Hogarth, Paul Chang, Kiran Turaga, Kevin Roggin, Mitchell C. Posner, Yuan Ji, Haley A. Coleman, Bruce M. Wollison, Matthew D. Ducar, Aaron R. Thorner, Andrew Dunford, David J. Oh, Agoston T. Agoston, Rick Lanman, Hideo Baba, Masayuki Watanabe, Lea O'Keefe, Katie S. Nason, Byung-Hoon Min, Min-Gew Choi, Kyoung-Mee Kim, Rebecca J. Nagy, John Hart, Shu-Yuan Xiao, Namrata Setia, Christopher Weber, Carrie Fitzpatrick, Rajani Kanteti, Melissa Maranto, Samantha Lomnicki, Emily O'Day, Kenisha Allen, Manish R. Sharma, Blase Polite, Hedy Kindler, Heewon Kwak, Lindsay Alpert, Mirazul Islam, Steven Maron, Yang Liu, Sarah Derks, Matthew D. Stachler, Eirini Pectasides

Supplementary Methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f45c965af6990a4bf960946e55a967
https://doi.org/10.1158/2159-8290.22534241.v1

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma

Autor: Haley A. Coleman, Gavin Ha, Lindsay Alpert, David J. Oh, Kevin K. Roggin, Jon M. Davison, Rick Lanman, Yang Liu, Rebecca J. Nagy, Emily O'Day, Jeeyun Lee, Shu-Yuan Xiao, Paul J. Chang, Min-Gew Choi, Viktor A. Adalsteinsson, Kyle Hogarth, Blase N. Polite, Hedy L. Kindler, Yuan Ji, Yu Imamura, Carrie Fitzpatrick, Steven Brad Maron, Katie S. Nason, Sarah Derks, Agoston T. Agoston, Justin Rhoades, Samantha Lomnicki, Namrata Setia, Kyoung-Mee Kim, Matthew D. Stachler, Hideo Baba, Daniel V.T. Catenacci, Melissa Maranto, John Hart, Lea O'Keefe, Samuel S. Freeman, Kiran K. Turaga, Andres Gelrud, Bruce M. Wollison, Masayuki Watanabe, Greg Gydush, Matthew D. Ducar, Kenisha Allen, Adam J. Bass, Manish R. Sharma, Denisse Rotem, Sarah C. Reed, Aaron R. Thorner, Uzma D. Siddiqui, Rajani Kanteti, Byung-Hoon Min, Mirazul Islam, Eirini Pectasides, Andrew Dunford, Christopher R. Weber, Heewon A. Kwak, Mitchell C. Posner

Publikováno v: Cancer discovery, vol 8, iss 1
Cancer discovery, 8(1), 37-48. American Association for Cancer Research Inc.
Pectasides, E, Stachler, M D, Derks, S, Liu, Y, Maron, S, Islam, M, Alpert, L, Kwak, H, Kindler, H, Polite, B, Sharma, M R, Allen, K, O’Day, E, Lomnicki, S, Maranto, M, Kanteti, R, Fitzpatrick, C, Weber, C, Setia, N, Xiao, S-Y, Hart, J, Nagy, R J, Kim, K-M, Choi, M-G, Min, B-H, Nason, K S, O’Keefe, L, Watanabe, M, Baba, H, Lanman, R, Agoston, A T, Oh, D J, Dunford, A, Thorner, A R, Ducar, M D, Wollison, B M, Coleman, H A, Ji, Y, Posner, M C, Roggin, K, Turaga, K, Chang, P, Hogarth, K, Siddiqui, U D, Gelrud, A, Ha, G, Freeman, S S, Rhoades, J, Reed, S, Gydush, G, Rotem, D, Davison, J, Imamura, Y, Adalsteinsson, V, Lee, J, Bass, A J & Catenacci, D V 2018, ' Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma ', Cancer discovery, vol. 8, no. 1, pp. 37-48 . https://doi.org/10.1158/2159-8290.CD-17-0395

Gastroesophageal adenocarcinoma (GEA) is a lethal disease where targeted therapies, even when guided by genomic biomarkers, have had limited efficacy. A potential reason for the failure of such therapies is that genomic profiling results could common

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6762e56b7dec008a6dbf500c08bce3d7
https://escholarship.org/uc/item/8205x8v8